Compounds > pd 153035

pd 153035 and 4-(3-chloroanilino)quinazoline

pd 153035 has been researched along with 4-(3-chloroanilino)quinazoline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridges, AJ; Cody, DR; Denny, WA; Fry, DW; McMichael, A; Rewcastle, GW; Zhou, H1
Bridges, AJ; Cody, DR; Denny, WA; Fry, DW; Kraker, AJ; McMichael, A; Rewcastle, GW; Showalter, HD; Zhou, H1
App, H; Chen, I; Chen, J; Gazit, A; Hirth, P; Levitzki, A; McMahon, G1
Bridges, AJ; Fry, DW; McMichael, A; Sercel, AD; Showalter, HD; Zhou, H1

Other Studies

4 other study(ies) available for pd 153035 and 4-(3-chloroanilino)quinazoline

ArticleYear
Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth fa
    Journal of medicinal chemistry, 1995, Sep-01, Volume: 38, Issue:18

    Topics: Adenosine Triphosphate; Amino Acid Sequence; ErbB Receptors; Humans; Molecular Sequence Data; Protein-Tyrosine Kinases; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured; Type C Phospholipases

1995
Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor.
    Journal of medicinal chemistry, 1996, Jan-05, Volume: 39, Issue:1

    Topics: Aniline Compounds; Binding Sites; Blotting, Western; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Humans; Kinetics; Molecular Conformation; Molecular Structure; Phosphorylation; Protein Binding; Quinazolines; Structure-Activity Relationship; Tumor Cells, Cultured

1996
Tyrphostins IV--highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolines.
    Bioorganic & medicinal chemistry, 1996, Volume: 4, Issue:8

    Topics: Aniline Compounds; ErbB Receptors; Phosphorylation; Protein Kinase C; Quinazolines; Staurosporine; Structure-Activity Relationship

1996
Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3, 2-d]pyrimidines and pyrimido[5,4-b-] and -[4,5-b]ĭndoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase.
    Journal of medicinal chemistry, 1999, Dec-30, Volume: 42, Issue:26

    Topics: Amino Acid Sequence; Enzyme Inhibitors; ErbB Receptors; Humans; Indoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Protein-Tyrosine Kinases; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured

1999